Alkermes plc
NASDAQ:ALKSBiotechnology
+$0.79 today
- Market cap
- $7.87B
- Beta
- 0.33
- P/E (TTM)
- 49.1
- EPS (TTM)
- $0.92
Volume 1.39M
Average 2.33M
ALKS Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Alkermes plcNASDAQ: ALKS
Operating Income · Q3 FY2026 · quarter ended Sep 2026
Operating income declines year over year
Q3 FY2026 operating income of $36.02M fell 59.6% year over year, ahead of the -82.1% change in trailing-twelve-month operating income. Sequentially, it rose 96.0% from the prior quarter.
Context
- Operating income amounted to 17.2% of revenue in FY2025, down 9.8 pp from a year earlier.
- Operating income increased in 2 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 14 analysts of -$58.28M (-123.0%) for the fiscal year ending Dec 2026, a slowdown from the -39.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $36.02M+96.0% QoQ
- Last fiscal yearDec 2025
- $253.96M-39.6% YoY
- LTMSep 2026
- $64.23M-82.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -59.6% | -122.0% | -62.5 pp |
| 1 year | -39.6% | -123.0% | -83.3 pp |
| 3-year CAGR | — | +36.8% | — |
| 5-year CAGR | +23.2% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 253.96M USD
- Year-over-year change
- -39.6%
- 4-year CAGR
- +27.0%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 253.96M | -39.6% |
| FY2024 | 2024-12-31 | 420.64M | +1.6% |
| FY2023 | 2023-12-31 | 414.12M | +6901.1% |
| FY2022 | 2022-12-31 | (6.09M) | -106.2% |
| FY2021 | 2021-12-31 | 97.75M | — |
Operating Income vs competitors
How ALKS compares with its peers on the latest reported figures
- ALKS's LTM Sep 2026 operating income of $64.23M is the 4th highest of the 7 companies compared; the peer median is $5.26M.
- Its year-over-year change of -82.1% is the 5th highest of 7, against a peer median of -15.8%.
- Operating income amounts to 3.7% of revenue for ALKS, versus a peer median of 22.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $957.8M | +293.9% | — | 20.3% | |
| LTM Sep 2026 | $881.2M | +60.2% | +35.5% | 23.8% | |
| LTM Sep 2026 | $122.33M | -49.2% | — | 10.2% | |
| LTM Sep 2026 | $64.23M | -82.1% | — | 3.7% | |
| LTM Jun 2026 | -$111.81M | -274.3% | — | 13.5% | |
| LTM Mar 2026 | -$160.36M | -111.1% | — | 73.6% | |
| LTM Jun 2026 | -$188.54M | +17.6% | — | 24.3% | |
| Peer median (excluding ALKS) | $5.26M | -15.8% | +35.5% | 22.1% | |
Competitors are the stored peer set for ALKS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 1.11B | 1.66B | 1.56B | 1.48B |
| Cost of Revenue | 197.32M | 218.07M | 253.04M | 245.33M | 196.46M |
| Gross Profit | 976.43M | 893.73M | 1.41B | 1.31B | 1.28B |
| Gross Margin | 83.2% | 80.4% | 84.8% | 84.2% | 86.7% |
| Research & Development | 290.92M | 272.7M | 270.81M | 245.33M | 323.96M |
| Selling, General & Admin | 549.61M | 590.75M | 689.75M | 645.24M | 714.52M |
| Operating Expenses | 878.68M | 899.82M | 996.25M | 891.67M | 1.03B |
| Depreciation & Amortization | 78.65M | 77.86M | 74.93M | 28.53M | 27.17M |
| EBITDA | 177.6M | 59.77M | 519.48M | 494.86M | 330.89M |
| EBITDA Margin | 15.1% | 5.4% | 31.2% | 31.8% | 22.4% |
| Operating Income | 97.75M | (6.09M) | 414.12M | 420.64M | 253.96M |
| Operating Margin | 8.3% | -0.5% | 24.9% | 27.0% | 17.2% |
| Interest Income | 2.41M | 7.63M | 30.85M | 42.45M | 45.3M |
| Interest Expense | 11.22M | 13.04M | 23.03M | 22.58M | 12.28M |
| Other Income / Expenses | (10.02M) | (25.04M) | 7.4M | 23.11M | 37.49M |
| Income Before Tax | 87.73M | (31.13M) | 421.52M | 443.75M | 291.45M |
| Pre-Tax Margin | 7.5% | -2.8% | 25.3% | 28.5% | 19.7% |
| Income Tax Expense | 11.33M | 2.02M | (97.64M) | 71.61M | 49.79M |
| Net Income | (48.17M) | (158.27M) | 355.76M | 367.07M | 241.66M |
| Net Margin | -4.1% | -14.2% | 21.4% | 23.6% | 16.4% |
| EPS (Basic) | (0.30) | (0.97) | 2.14 | 2.22 | 1.47 |
| EPS (Diluted) | (0.30) | (0.97) | 2.10 | 2.17 | 1.43 |
| Weighted Avg Shares | 160.94M | 163.74M | 166.22M | 165.39M | 164.7M |
| Weighted Avg Shares (Diluted) | 160.94M | 163.74M | 169.73M | 169.2M | 168.74M |
Alkermes plc
NASDAQ:ALKS
Intrinsic Alpha fair value
Locked
Current Price
$46.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.